Dr. Patrick Ott, MD, PhD
Claim this profileDana Farber Cancer Institute
Studies Melanoma
Studies Skin Cancer
6 reported clinical trials
8 drugs studied
Area of expertise
1Melanoma
Stage III
Stage IV
Stage II
2Skin Cancer
Stage III
Stage IV
MSI-H positive
Affiliated Hospitals
Clinical Trials Patrick Ott, MD, PhD is currently running
Nivolumab
for Cancer
This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Recruiting1 award Phase 120 criteria
NeoVax + CDX-301 + Nivolumab
for Melanoma
This trial is testing a personalized vaccine called NeoVax, combined with other drugs, to treat melanoma. The vaccine is made from the patient's own tumor proteins to help the immune system fight cancer. The study aims to find a safe way to use these treatments together and determine the right dose.
Recruiting1 award Phase 120 criteria
More about Patrick Ott, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Patrick Ott, MD, PhD has experience with
- Nivolumab
- Ipilimumab
- NeoVax Plus Montanide
- Personalized NeoAntigen Cancer Vaccine
- CDX-301
- NEOVAX
Breakdown of trials Patrick Ott, MD, PhD has run
Melanoma
Skin Cancer
Kidney Cancer
Cutaneous Melanoma
Merkel Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick Ott, MD, PhD specialize in?
Patrick Ott, MD, PhD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage III patients, or patients who are Stage IV.
Is Patrick Ott, MD, PhD currently recruiting for clinical trials?
Yes, Patrick Ott, MD, PhD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Patrick Ott, MD, PhD has studied deeply?
Yes, Patrick Ott, MD, PhD has studied treatments such as Nivolumab, Ipilimumab, NeoVax plus Montanide.
What is the best way to schedule an appointment with Patrick Ott, MD, PhD?
Apply for one of the trials that Patrick Ott, MD, PhD is conducting.
What is the office address of Patrick Ott, MD, PhD?
The office of Patrick Ott, MD, PhD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.